175 related articles for article (PubMed ID: 25973233)
1. Elevated expression of USP9X correlates with poor prognosis in human non-small cell lung cancer.
Wang Y; Liu Y; Yang B; Cao H; Yang CX; Ouyang W; Zhang SM; Yang GF; Zhou FX; Zhou YF; Xie CH
J Thorac Dis; 2015 Apr; 7(4):672-9. PubMed ID: 25973233
[TBL] [Abstract][Full Text] [Related]
2. [Expression of USP9X in Non-small Cell Lung Cancer and Its Clinical Significance].
Peng J; Hu Q; Liu WP; Liu SL; Wang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):413-6. PubMed ID: 26121864
[TBL] [Abstract][Full Text] [Related]
3. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
4. Testes-specific protease 50 as an independent risk factor for poor prognosis in patients with non-small cell lung cancer.
Qiao WL; Shi BW; Han YD; Tang HM; Lin J; Hu HY; Lin Q
Oncol Lett; 2018 Jun; 15(6):8796-8804. PubMed ID: 29805619
[TBL] [Abstract][Full Text] [Related]
5. A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer.
Chen X; Yu C; Gao J; Zhu H; Cui B; Zhang T; Zhou Y; Liu Q; He H; Xiao R; Huang R; Xie H; Gao D; Zhou H
Theranostics; 2018; 8(9):2348-2360. PubMed ID: 29721084
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer.
Fu X; Xie W; Song X; Wu K; Xiao L; Liu Y; Zhang L
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):687-692. PubMed ID: 28274596
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of USP9X is associated with poor prognosis in Chinese pancreatic ductal adenocarcinoma patients.
Liu W; Huo Y; Yang J; Fu X; Yang M; Tao L; Liu D; Zhang J; Hua R; Sun Y
Oncol Lett; 2018 Jun; 15(6):9287-9292. PubMed ID: 29844826
[TBL] [Abstract][Full Text] [Related]
8. [Expression of FATS in non-small cell lung cancer and its relationship with prognosis].
Zhang TM; Zhang J; Zhou DJ; Wang CL
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):826-830. PubMed ID: 31770849
[No Abstract] [Full Text] [Related]
9. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
10. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014 Apr; ():. PubMed ID: 24712844
[TBL] [Abstract][Full Text] [Related]
11. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
13. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
14. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
15. B3GNT3 overexpression is associated with unfavourable survival in non-small cell lung cancer.
Gao L; Zhang H; Zhang B; Zhu J; Chen C; Liu W
J Clin Pathol; 2018 Jul; 71(7):642-647. PubMed ID: 29483137
[TBL] [Abstract][Full Text] [Related]
16. miR-1290 is a potential prognostic biomarker in non-small cell lung cancer.
Mo D; Gu B; Gong X; Wu L; Wang H; Jiang Y; Zhang B; Zhang M; Zhang Y; Xu J; Pan S
J Thorac Dis; 2015 Sep; 7(9):1570-9. PubMed ID: 26543604
[TBL] [Abstract][Full Text] [Related]
17. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of RelB overexpression in non-small cell lung cancer patients.
Qin H; Zhou J; Zhou P; Xu J; Tang Z; Ma H; Guo F
Thorac Cancer; 2016 Jul; 7(4):415-21. PubMed ID: 27385983
[TBL] [Abstract][Full Text] [Related]
19. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
[TBL] [Abstract][Full Text] [Related]
20. Tazarotene-induced gene 2 is associated with poor survival in non-small cell lung cancer.
Cai Q; Huang Z; Qi L; Wang T; Shen Y; Huang J
Oncol Lett; 2016 Oct; 12(4):2680-2685. PubMed ID: 27698842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
